FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2024 results of operations
FDA Expands Indication for Gilead`s Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
Laurus Labs` Generic Bictegravir, Emtricitabine, Tenofovir Alafenamide Receives Approval in the U.S.
FDA Confirms Paragraph IV Patent Litigation for Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide Tablets
With ViiV declining to participate in a self-regulatory process, the National Advertising Division referred the case to a pair of federal agencies.
Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S.FDA) for its abbreviated New Drug Application for Tenofovir Alafenamide tablets, 25 mg, via an exchange filing.
Lupin's Generic Tenofovir Alafenamide Receives Approval in the U.S.
Pharmaceutical firm Lupin Ltd on Tuesday said it has received tentative approval from the US health regulator for its new drug application Dolutegravir, Emtricitabine and Tenofovir Alafenamide (DETAF) tablets.
Lupin's Generic Dolutegravir Sodium, Emtricitabine and Receives Approval in the U.S.